Non-tuberculous mycobacteria in the sputum of HIV-infected patients: Infection or colonization

International Journal of STD and AIDS

Volumn 20, Issue 3, 2009, Pages 193-195

  Alvarez Uria, G ^a,b,c   Falco V ^a,b   Martin Casabona N ^a,b   Crespo, M ^a   Del Saz, S Villar ^a   Curran, A ^a   Ocana I ^b   Ribera, E ^a   Pahissa, A ^a,b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c NORTH MANCHESTER GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cd4 lymphocyte count; Haemoglobin; Mycobacterium avium complex; Mycobacterium kansasii; Mycobacterium xenopi

Indexed keywords

HEMOGLOBIN;

ACID FAST BACTERIUM; ADULT; ANEMIA; ARTICLE; ATYPICAL MYCOBACTERIOSIS; ATYPICAL MYCOBACTERIUM; BACTERIAL COLONIZATION; BACTERIUM ISOLATION; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONFIDENCE INTERVAL; DISEASE DURATION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; MALE; NONTUBERCULOUS MYCOBACTERIA; PRIORITY JOURNAL; SPUTUM ANALYSIS; SPUTUM CULTURE; WEIGHT REDUCTION;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; FEMALE; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIA, ATYPICAL; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM KANSASII; MYCOBACTERIUM XENOPI; SPUTUM; STATISTICS, NONPARAMETRIC; WEIGHT LOSS;

EID: 62249120391     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008300     Document Type: Article

References (14)

1. Falkinham JO III. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529-51
2. Shrestha NK. Rapid diagnostic testing for mycobacterial infections. Future Microbiol 2007;2:397-408
3. Kaplan JE, Hanson D, Dworkin MS, et al Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000;30:S5-14
4. Gordin FM, Cohn DL, Sullam PM, Schoenfelder JR, Wynne BA, Horsburgh CR Jr. Early manifestations of disseminated Mycobacterium avium complex disease: a prospective evaluation. J Infect Dis 1997;176:126-32
5. Rolla V, Jacomet C, Salause B, et al. Clinical and laboratory findings of disseminated Mycobacterium avium complex infection (DMAC) in a pair matched case-control study. Rev Inst Med Trop Sao Paulo 1999;41:273-7
6. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367-416
7. Witzig RS, Fazal BA, Mera RM, et al. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1. Clin Infect Dis 1995;21:77-85
8. Kerbiriou L, Ustianowski A, Johnson MA, Gillespie SH, Miller RF, Lipman MC. Human immunodeficiency virus type 1-related pulmonary Mycobacterium xenopi infection: a need to treat? Clin Infect Dis 2003;37:1250 -4
9. Meybeck A, Fortin C, Abgrall S, et al. Spondylitis due to Mycobacterium xenopi in a human immunodeficiency virus type 1-infected patient: case report and review of the literature. J Clin Microbiol 2005;43:1465-6
10. van IJ, Boeree MJ, de Lange WC, et al. Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 2008;14:385-9
11. O'Brien RJ, Geiter LJ, Snider DE Jr. The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 1987;135:1007-14
12. Horsburgh CR Jr. The pathophysiology of disseminated Mycobacterium avium complex disease in AIDS. J Infect Dis 1999;179:S461-5
13. Marras TK, Morris A, Gonzalez LC, Daley CL. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus. Am J Respir Crit Care Med 2004;170:793-8
14. Phillips P, Bonner S, Gataric N, et al. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up. Clin Infect Dis 2005;41:1483- 97